AGP Executive Report
Last update: 7 hours agoMedicine Manufacturing: Reykjavík-based Alvotech won FDA approval for a new SIMLANDI manufacturing process that more than doubles drug-substance output per batch. The Humira biosimilar treats chronic inflammatory diseases, and the added capacity could help meet demand and free resources for other medicines. Obesity Care: A European review backed extending QSIVA, a weight-management medicine, to patients aged 12 and older with obesity. Iceland is among 17 countries awaiting national decisions; the treatment is intended to complement lifestyle changes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.